Ftse Mib
35.212,25
0,25%
DAX
20.299,93
0,19%
S&P 500
5.842,91
0,11%
NASDAQ
19.044,39
-0,23%
Bitcoin
97.475,70
1,01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kintara Therapeutics Inc (KTRA) Kintara Therapeutics Inc (KTRA) Notizie

Kintara Therapeutics Inc

KTRA
7,539
0,00 (0,00%)
15 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/1/202522:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202415:07EDGAR2Form 425 - Prospectuses and communications, business..
12/12/202415:03EDGAR2Form 8-K - Current report
25/11/202414:55EDGAR2Form 8-K - Current report
15/11/202423:00EDGAR2Form 8-K - Current report
14/11/202423:20EDGAR2Form 8-K/A - Current report: [Amend]
14/11/202423:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202422:30EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
25/10/202422:28EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
25/10/202422:26EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
25/10/202422:23EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
25/10/202422:20EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
23/10/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202402:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/10/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202402:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/10/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202402:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/10/202402:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/10/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202401:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/10/202414:30EDGAR2Form 8-K - Current report
16/10/202418:54PRNUSKintara Therapeutics Announces Correction to Prior..
16/10/202417:58PRNUSKintara Therapeutics Announces 1-for-35 Reverse Stock Split..
16/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
15/10/202422:20EDGAR2Form 8-K - Current report
15/10/202422:15PRNUSKintara Therapeutics Announces Correction to Prior..
15/10/202414:30EDGAR2Form 8-K - Current report
14/10/202414:30PRNUSKintara Therapeutics Announces Record Date for CVR Issuance..
08/10/202422:05EDGAR2Form POS AM - Post-Effective amendments for registration..
08/10/202422:05EDGAR2Form 8-K - Current report
08/10/202413:05EDGAR2Form 8-K - Current report
08/10/202413:00PRNUSKintara Therapeutics Announces Fiscal 2024 Financial Results..
07/10/202423:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/10/202422:10EDGAR2Form 425 - Prospectuses and communications, business..
04/10/202422:05EDGAR2Form 8-K - Current report
30/9/202423:20EDGAR2Form NT 10-K - Notification of inability to timely file Form..
25/9/202423:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/9/202423:05EDGAR2Form 425 - Prospectuses and communications, business..
25/9/202423:00EDGAR2Form 8-K - Current report
24/9/202414:35EDGAR2Form 425 - Prospectuses and communications, business..
24/9/202414:30EDGAR2Form 8-K - Current report
20/9/202422:20EDGAR2Form 425 - Prospectuses and communications, business..
20/9/202422:15EDGAR2Form 8-K - Current report
20/9/202415:25PRNUSKintara Therapeutics Announces Adjournment of Special..
18/9/202414:40EDGAR2Form 425 - Prospectuses and communications, business..
18/9/202414:35EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 7,539

La tua Cronologia

NASDAQ
KTRA
Kintara Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network